BREAST-CANCER - ADVANCES IN MANAGEMENT

被引：3
作者：
BRODIE, GN
ELEFANTY, A
机构：
来源：
DRUGS | 1988年 / 35卷 / 05期
关键词：
D O I：
10.2165/00003495-198835050-00006
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：584 / 595
页数：12
相关论文
共 57 条
[1]  
[Anonymous], 1984, Lancet, V2, P1205
[2]  
BEADLE GF, 1984, CANCER, V54, P2911, DOI 10.1002/1097-0142(19841215)54:12<2911::AID-CNCR2820541216>3.0.CO
[3]  
2-V
[4]   COMBINATION CHEMOTHERAPY AS AN ADJUVANT TREATMENT IN OPERABLE BREAST-CANCER [J].
BONADONNA, G ;
BRUSAMOLINO, E ;
VALAGUSSA, P ;
ROSSI, A ;
BRUGNATELLI, L ;
BRAMBILLA, C ;
DELENA, M ;
TANCINI, G ;
BAJETTA, E ;
MUSUMECI, R ;
VERONESI, U .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (08) :405-410
[5]   DOSE-RESPONSE EFFECT OF ADJUVANT CHEMOTHERAPY IN BREAST-CANCER [J].
BONADONNA, G ;
VALAGUSSA, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (01) :10-15
[6]  
BONADONNA G, 1983, LANCET, V1, P1157
[7]  
BONADONNA G, 1986, SEMINARS ONCOLOGY, V14, P8
[8]   PROGESTERONE RECEPTORS AS A PROGNOSTIC FACTOR IN STAGE-II BREAST-CANCER [J].
CLARK, GM ;
MCGUIRE, WL ;
HUBAY, CA ;
PEARSON, OH ;
MARSHALL, JS .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (22) :1343-1347
[9]  
DANOFF B, 1985, INT J RAD ONCOLOG S1, V2, P104
[10]  
DUPONT WD, 1985, NEW ENGLAND J MED, V312, P137
123456